Bangkok Dusit Medical Services Public Company Limited
Bangkok Dusit Medical Services Public Company Limited Fundamental Analysis
Bangkok Dusit Medical Services Public Company Limited (BDUUY) shows moderate financial fundamentals with a PE ratio of 16.78, profit margin of 14.22%, and ROE of 15.30%. The company generates $110.9B in annual revenue with moderate year-over-year growth of 6.96%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BDUUY's fundamental strength across five key dimensions:
Efficiency Score
WeakBDUUY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentBDUUY trades at attractive valuation levels.
Growth Score
ExcellentBDUUY delivers strong and consistent growth momentum.
Financial Health Score
ModerateBDUUY shows balanced financial health with some risks.
Profitability Score
ModerateBDUUY maintains healthy but balanced margins.
Key Financial Metrics
Is BDUUY Expensive or Cheap?
P/E Ratio
BDUUY trades at 16.78 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, BDUUY's PEG of -0.13 indicates potential undervaluation.
Price to Book
The market values Bangkok Dusit Medical Services Public Company Limited at 2.50 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.27 times EBITDA. This is generally considered low.
How Well Does BDUUY Make Money?
Net Profit Margin
For every $100 in sales, Bangkok Dusit Medical Services Public Company Limited keeps $14.22 as profit after all expenses.
Operating Margin
Core operations generate 17.64 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.30 in profit for every $100 of shareholder equity.
ROA
Bangkok Dusit Medical Services Public Company Limited generates $9.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bangkok Dusit Medical Services Public Company Limited produces operating cash flow of $23.12B, showing steady but balanced cash generation.
Free Cash Flow
Bangkok Dusit Medical Services Public Company Limited generates strong free cash flow of $12.21B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $30.74 in free cash annually.
FCF Yield
BDUUY converts 4.62% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.78
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.50
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.39
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.24
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.98
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How BDUUY Stacks Against Its Sector Peers
| Metric | BDUUY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.78 | 27.91 | Better (Cheaper) |
| ROE | 15.30% | 687.00% | Weak |
| Net Margin | 14.22% | -45285.00% (disorted) | Strong |
| Debt/Equity | 0.24 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 0.98 | 2795.76 | Weak Liquidity |
| ROA | 9.98% | -13557.00% (disorted) | Weak |
BDUUY outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bangkok Dusit Medical Services Public Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
29.17%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
2.06%
Industry Style: Defensive, Growth, Innovation
GrowingFCF CAGR
56.35%
Industry Style: Defensive, Growth, Innovation
High Growth